Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY01005 vs goserelin depot in premenopausal ER+ breast cancer
CTR20201955Phase 3Completed
- Sponsor
- Luye Pharma Group
- Start
- Oct 2020
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of Baituowei in breast cancer, sponsored by Luye Pharma Group. Started Oct 2020; status: completed.
02
Drugs
Baituowei
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20201955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201955.